Industry in brief | Boiron, Taisho/UPSA, BioGaia

2 July 2019 - Deborah Wilkes

Archived

Boiron has criticised a French recommendation on homoeopathy, Taisho Pharmaceutical has completed its planned acquisition of UPSA, and BioGaia has announced a deal with Abbott in Uruguay.

Click tags below for more information on topics:

Boiron Homeopathy Taisho BioGaia

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: